Investors with the goal of beating the broader market often turn to stock selection. Strategic choices in individual stocks can have a profound impact on your wealth.
The closing price of Geron Corp (NASDAQ: GERN) was $2.82 for the day, down -3.75% from the previous closing price of $2.93. In other words, the price has decreased by -$3.75 from its previous closing price. On the day, 20.33 million shares were traded. GERN stock price reached its highest trading level at $2.96 during the session, while it also had its lowest trading level at $2.76.
Ratios:
Our analysis of GERN’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 2.74 and its Current Ratio is at 2.89. In the meantime, Its Debt-to-Equity ratio is 0.30 whereas as Long-Term Debt/Eq ratio is at 0.05.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, H.C. Wainwright on November 05, 2024, initiated with a Buy rating and assigned the stock a target price of $8.
On September 09, 2024, Leerink Partners started tracking the stock assigning a Outperform rating and target price of $7.Leerink Partners initiated its Outperform rating on September 09, 2024, with a $7 target price.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Jul 08 ’24 when GRETHLEIN ANDREW J sold 674,348 shares for $4.56 per share. The transaction valued at 3,073,004 led to the insider holds 0 shares of the business.
Feller Faye sold 287,900 shares of GERN for $1,334,129 on Jun 10 ’24. The EVP, Chief Medical Officer now owns 0 shares after completing the transaction at $4.63 per share. On Jun 10 ’24, another insider, Kapur Anil, who serves as the EVP, Corp Strategy & CCO of the company, sold 421,875 shares for $4.64 each. As a result, the insider received 1,959,609 and left with 0 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, GERN now has a Market Capitalization of 1704692736 and an Enterprise Value of 1452181888. For the stock, the TTM Price-to-Sale (P/S) ratio is 57.83 while its Price-to-Book (P/B) ratio in mrq is 5.82. Its current Enterprise Value per Revenue stands at 49.26 whereas that against EBITDA is -7.0.
Stock Price History:
The Beta on a monthly basis for GERN is 0.46, which has changed by 0.41545892 over the last 52 weeks, in comparison to a change of 0.21659255 over the same period for the S&P500. Over the past 52 weeks, GERN has reached a high of $5.34, while it has fallen to a 52-week low of $1.64. The 50-Day Moving Average of the stock is -17.20%, while the 200-Day Moving Average is calculated to be -30.59%.
Shares Statistics:
GERN traded an average of 10.53M shares per day over the past three months and 11059730 shares per day over the past ten days. A total of 603.10M shares are outstanding, with a floating share count of 564.59M. Insiders hold about 6.60% of the company’s shares, while institutions hold 78.78% stake in the company. Shares short for GERN as of 1736899200 were 73708963 with a Short Ratio of 7.00, compared to 1734048000 on 64524457. Therefore, it implies a Short% of Shares Outstanding of 73708963 and a Short% of Float of 12.2600004.
